Chemotherapy Clinical Guidelines
Clinical Guidelines
| Title | Review Date |
| NCA Chemotherapy Administration Policy v1.6 2018.03.16 | 30.03.2021 |
| ALLERGIC Reactions and HYPERSENSITIVITY Policy v1.5 | January 2021 |
| ANTIEMETIC guidelines for CINV v2.5 | March 2021 |
| EXTRAVASATION Guidelines v5.5 | November 2019 |
| SAVENE Pt Referral Form v4.0 | January 2021 |
| NCA Guidelines for Community Management of Chemotherapy Toxicity v1.5 | 20.06.2021 |
| NCA 24 Hour Telephone Advice Specification v1.4 June 18 | 10.06.2021 |
| Adult VENOUS ACCESS and CVAD Policy v3.0 | January 2021 |
| NCA Oral Anticancer medicine Policy version 1 8 | January 2020 |
| NCA Policy on scalp cooling to prevent alopecia v1.4 | 20.06.2021 |
| Policy for the use of ERYTHROPOETINS for cancer treatment induced anaemia v1.6 | January 2021 |
| NECN Non Medical Prescribing Review Guidance v2.2 16.07.18 | September 2021 |
| G-CSF Guidelines v1.5 | January 2021 |
Training Guidelines
| Title | Review Date |
| Assessment of COMPETENCE Policy v2.4 | March 2021 |
| Chemotherapy NURSE TRAINING Policy v3.0 | Feb 2021 |
Patient Information
| Title | Review Date |
| NCA Influenza leaflet 2019 v3.0 | September 2022 |
| Trastuzumab Biosimilar Information Leaflet | 24.03.2021 |
Miscellaneous Documents
| Title | Review Date |
| New Drug Capacity Calculator | |
| Capacity Calculator User Manual UK_ONC_0013_13d(1) | |
| Monitoring for DPD toxicity Guidelines template March 2018 | March 2020 |
Links to Other resources
Liverpool Cancer Drug Interactions (endorsed by BOPA)
BOPA (British Oncology Pharmacy Association) home page
UKONS (UK Oncology Nursing Society) home page
ACP (Association of Cancer Physicians) home page